QGEN: QIAGEN N.V. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10,653.85
Enterprise Value ($M) 11,827.03
Book Value ($M) 3,240.14
Book Value / Share 14.25
Price / Book 3.29
NCAV ($M) -846.89
NCAV / Share -3.72
Price / NCAV -12.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) 0.09
Return on Equity (ROE) 0.19

Liquidity (mrq)
Quick Ratio 1.85
Current Ratio 2.19

Balance Sheet (mrq) ($M)
Current Assets 2,097.25
Assets 6,184.28
Liabilities 2,944.14
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,251.66
Operating Income 669.35
Net Income 512.60

Cash Flow Statement (mra) ($M)
Cash From Operations 639.00
Cash from Investing -202.43
Cash from Financing -150.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-02 13G/A Massachusetts Financial Services Co /ma/ 9.00 73.61
01-27 13G/A BlackRock Inc. 13.50 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-06-28 89,451 703,474 12.72
2022-06-27 120,539 914,074 13.19
2022-06-24 90,188 1,015,704 8.88
2022-06-23 69,765 634,035 11.00

(click for more detail)

(click for list of largest short owners)

Similar Companies
PBH – Prestige Brands Holdings, Inc. PFE – Pfizer Inc.
PRGO – Perrigo Company PLC RCUS – Arcus Biosciences Inc
RDY – Dr. Reddy's Laboratories Ltd.


Financial data and stock pages provided by
Fintel.io